nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—ALB—focal segmental glomerulosclerosis	0.414	1	CbGaD
Nateglinide—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.105	0.215	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0957	0.196	CbGbCtD
Nateglinide—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0957	0.196	CbGbCtD
Nateglinide—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0718	0.147	CbGbCtD
Nateglinide—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0482	0.0986	CbGbCtD
Nateglinide—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.044	0.0902	CbGbCtD
Nateglinide—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.028	0.0573	CbGbCtD
Nateglinide—PPARG—nephron—focal segmental glomerulosclerosis	0.00925	0.164	CbGeAlD
Nateglinide—PPARG—endothelium—focal segmental glomerulosclerosis	0.00436	0.0775	CbGeAlD
Nateglinide—UGT1A9—kidney—focal segmental glomerulosclerosis	0.00357	0.0634	CbGeAlD
Nateglinide—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.003	0.0534	CbGeAlD
Nateglinide—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00287	0.051	CbGeAlD
Nateglinide—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00257	0.0457	CbGeAlD
Nateglinide—SLC15A1—nephron tubule—focal segmental glomerulosclerosis	0.0025	0.0445	CbGeAlD
Nateglinide—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00246	0.0437	CbGeAlD
Nateglinide—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00233	0.0414	CbGeAlD
Nateglinide—ABCC8—kidney—focal segmental glomerulosclerosis	0.0023	0.0409	CbGeAlD
Nateglinide—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.113	CcSEcCtD
Nateglinide—SLC15A1—kidney—focal segmental glomerulosclerosis	0.0022	0.0391	CbGeAlD
Nateglinide—SLC16A1—kidney—focal segmental glomerulosclerosis	0.00209	0.0372	CbGeAlD
Nateglinide—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0915	CcSEcCtD
Nateglinide—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.00181	0.0322	CbGeAlD
Nateglinide—PPARG—kidney—focal segmental glomerulosclerosis	0.00175	0.0312	CbGeAlD
Nateglinide—ABCC4—kidney—focal segmental glomerulosclerosis	0.00159	0.0283	CbGeAlD
Nateglinide—SLC15A2—nephron tubule—focal segmental glomerulosclerosis	0.00156	0.0278	CbGeAlD
Nateglinide—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.00155	0.0276	CbGeAlD
Nateglinide—Spirapril—ACE—focal segmental glomerulosclerosis	0.00148	0.194	CrCbGaD
Nateglinide—SLC15A2—kidney—focal segmental glomerulosclerosis	0.00137	0.0244	CbGeAlD
Nateglinide—SLC15A2—cortex of kidney—focal segmental glomerulosclerosis	0.00134	0.0238	CbGeAlD
Nateglinide—Lisinopril—ACE—focal segmental glomerulosclerosis	0.00132	0.173	CrCbGaD
Nateglinide—Cilazapril—ACE—focal segmental glomerulosclerosis	0.00132	0.173	CrCbGaD
Nateglinide—Ramipril—ACE—focal segmental glomerulosclerosis	0.00127	0.167	CrCbGaD
Nateglinide—Trandolapril—ACE—focal segmental glomerulosclerosis	0.00127	0.167	CrCbGaD
Nateglinide—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0592	CcSEcCtD
Nateglinide—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00119	0.0211	CbGeAlD
Nateglinide—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.00113	0.0803	CbGpPWpGaD
Nateglinide—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00104	0.0186	CbGeAlD
Nateglinide—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00102	0.0181	CbGeAlD
Nateglinide—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000985	0.0486	CcSEcCtD
Nateglinide—Enalapril—ACE—focal segmental glomerulosclerosis	0.000966	0.127	CrCbGaD
Nateglinide—PTGS1—kidney—focal segmental glomerulosclerosis	0.000938	0.0167	CbGeAlD
Nateglinide—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.000901	0.0445	CcSEcCtD
Nateglinide—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00086	0.0425	CcSEcCtD
Nateglinide—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000842	0.0416	CcSEcCtD
Nateglinide—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00081	0.04	CcSEcCtD
Nateglinide—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.0391	CcSEcCtD
Nateglinide—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000784	0.0139	CbGeAlD
Nateglinide—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000771	0.0137	CbGeAlD
Nateglinide—PPARG—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.000696	0.0492	CbGpPWpGaD
Nateglinide—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.000672	0.0475	CbGpPWpGaD
Nateglinide—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000666	0.0329	CcSEcCtD
Nateglinide—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.0325	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000635	0.0314	CcSEcCtD
Nateglinide—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.0295	CcSEcCtD
Nateglinide—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.0293	CcSEcCtD
Nateglinide—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.0285	CcSEcCtD
Nateglinide—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000476	0.0235	CcSEcCtD
Nateglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.000453	0.032	CbGpPWpGaD
Nateglinide—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000446	0.022	CcSEcCtD
Nateglinide—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000416	0.0205	CcSEcCtD
Nateglinide—ABCC4—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000391	0.0277	CbGpPWpGaD
Nateglinide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000376	0.0186	CcSEcCtD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000372	0.0264	CbGpPWpGaD
Nateglinide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000342	0.0169	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.0166	CcSEcCtD
Nateglinide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.0166	CcSEcCtD
Nateglinide—ABCC4—Ectoderm Differentiation—PODXL—focal segmental glomerulosclerosis	0.000322	0.0228	CbGpPWpGaD
Nateglinide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.0157	CcSEcCtD
Nateglinide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.0153	CcSEcCtD
Nateglinide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.0152	CcSEcCtD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—ANGPT2—focal segmental glomerulosclerosis	0.000296	0.0209	CbGpPWpGaD
Nateglinide—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.0141	CcSEcCtD
Nateglinide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000279	0.0138	CcSEcCtD
Nateglinide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.0136	CcSEcCtD
Nateglinide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000266	0.0131	CcSEcCtD
Nateglinide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000257	0.0127	CcSEcCtD
Nateglinide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.0122	CcSEcCtD
Nateglinide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.0121	CcSEcCtD
Nateglinide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.0121	CcSEcCtD
Nateglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000233	0.0165	CbGpPWpGaD
Nateglinide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.0114	CcSEcCtD
Nateglinide—ABCC8—Regulation of insulin secretion—GNAQ—focal segmental glomerulosclerosis	0.000227	0.0161	CbGpPWpGaD
Nateglinide—KCNJ11—Regulation of insulin secretion—GNAQ—focal segmental glomerulosclerosis	0.00022	0.0156	CbGpPWpGaD
Nateglinide—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000207	0.0147	CbGpPWpGaD
Nateglinide—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000192	0.0136	CbGpPWpGaD
Nateglinide—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.000188	0.0133	CbGpPWpGaD
Nateglinide—ABCC8—Integration of energy metabolism—GNAQ—focal segmental glomerulosclerosis	0.000178	0.0126	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000177	0.0125	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000176	0.0125	CbGpPWpGaD
Nateglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.000175	0.0124	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000173	0.0123	CbGpPWpGaD
Nateglinide—KCNJ11—Integration of energy metabolism—GNAQ—focal segmental glomerulosclerosis	0.000173	0.0122	CbGpPWpGaD
Nateglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.00017	0.012	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000169	0.0119	CbGpPWpGaD
Nateglinide—PPARG—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.000134	0.00945	CbGpPWpGaD
Nateglinide—PPARG—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000133	0.00939	CbGpPWpGaD
Nateglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00013	0.00919	CbGpPWpGaD
Nateglinide—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000127	0.00902	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.000122	0.00866	CbGpPWpGaD
Nateglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000121	0.00857	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00012	0.00849	CbGpPWpGaD
Nateglinide—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000117	0.00828	CbGpPWpGaD
Nateglinide—UGT1A9—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000114	0.00807	CbGpPWpGaD
Nateglinide—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000112	0.0079	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—FN1—focal segmental glomerulosclerosis	0.000105	0.00746	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000104	0.00737	CbGpPWpGaD
Nateglinide—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000102	0.00724	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—FN1—focal segmental glomerulosclerosis	9.32e-05	0.0066	CbGpPWpGaD
Nateglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	8.95e-05	0.00633	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ACTN4—focal segmental glomerulosclerosis	8.94e-05	0.00633	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	8.88e-05	0.00629	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	8.32e-05	0.00589	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—LPL—focal segmental glomerulosclerosis	8.04e-05	0.00569	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	8.03e-05	0.00568	CbGpPWpGaD
Nateglinide—PPARG—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	7.87e-05	0.00557	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	7.85e-05	0.00555	CbGpPWpGaD
Nateglinide—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	7.77e-05	0.0055	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	7.76e-05	0.00549	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—ALB—focal segmental glomerulosclerosis	7.74e-05	0.00548	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	7.7e-05	0.00545	CbGpPWpGaD
Nateglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	7.7e-05	0.00545	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	7.69e-05	0.00544	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	7.55e-05	0.00534	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	7.39e-05	0.00523	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	7.38e-05	0.00522	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	7.08e-05	0.00501	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	6.95e-05	0.00492	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—AGT—focal segmental glomerulosclerosis	6.88e-05	0.00487	CbGpPWpGaD
Nateglinide—UGT1A9—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	6.76e-05	0.00478	CbGpPWpGaD
Nateglinide—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	6.62e-05	0.00468	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	6.59e-05	0.00466	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	5.98e-05	0.00424	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	5.98e-05	0.00423	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TRPC6—focal segmental glomerulosclerosis	5.75e-05	0.00407	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MYH9—focal segmental glomerulosclerosis	5.7e-05	0.00404	CbGpPWpGaD
Nateglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	5.3e-05	0.00375	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	5.29e-05	0.00375	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.21e-05	0.00369	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	5.08e-05	0.00359	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	5.06e-05	0.00358	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	5.06e-05	0.00358	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	5.03e-05	0.00356	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.98e-05	0.00352	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	4.9e-05	0.00347	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—GNAQ—focal segmental glomerulosclerosis	4.81e-05	0.0034	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.69e-05	0.00332	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	4.67e-05	0.0033	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	4.56e-05	0.00323	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	4.43e-05	0.00314	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	4.4e-05	0.00311	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.35e-05	0.00308	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TRPC6—focal segmental glomerulosclerosis	4.29e-05	0.00304	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	4.24e-05	0.003	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	4.22e-05	0.00299	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	4.14e-05	0.00293	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	4.09e-05	0.0029	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.05e-05	0.00286	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	4.04e-05	0.00286	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	4.04e-05	0.00286	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	4.02e-05	0.00284	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.81e-05	0.0027	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	3.76e-05	0.00266	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	3.73e-05	0.00264	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.71e-05	0.00263	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—GNAQ—focal segmental glomerulosclerosis	3.58e-05	0.00254	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.56e-05	0.00252	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.54e-05	0.0025	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	3.51e-05	0.00248	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.48e-05	0.00246	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	3.44e-05	0.00244	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	3.43e-05	0.00243	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	3.34e-05	0.00237	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	3.34e-05	0.00236	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	3.25e-05	0.0023	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.23e-05	0.00229	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	3.15e-05	0.00223	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.06e-05	0.00217	CbGpPWpGaD
Nateglinide—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	3.03e-05	0.00214	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—FN1—focal segmental glomerulosclerosis	2.86e-05	0.00202	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.83e-05	0.00201	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.83e-05	0.002	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—LPL—focal segmental glomerulosclerosis	2.76e-05	0.00196	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	2.71e-05	0.00192	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.63e-05	0.00186	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.62e-05	0.00185	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—LIPC—focal segmental glomerulosclerosis	2.51e-05	0.00178	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.5e-05	0.00177	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.47e-05	0.00175	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—LIPC—focal segmental glomerulosclerosis	2.44e-05	0.00173	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.4e-05	0.0017	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	2.38e-05	0.00168	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ALB—focal segmental glomerulosclerosis	2.37e-05	0.00168	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	2.22e-05	0.00157	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CTGF—focal segmental glomerulosclerosis	2.21e-05	0.00157	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	2.17e-05	0.00154	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.15e-05	0.00152	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CTGF—focal segmental glomerulosclerosis	2.15e-05	0.00152	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	2.13e-05	0.00151	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.12e-05	0.0015	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.12e-05	0.0015	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.11e-05	0.0015	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	2.11e-05	0.00149	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.11e-05	0.00149	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.06e-05	0.00145	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—CTGF—focal segmental glomerulosclerosis	2.04e-05	0.00144	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.04e-05	0.00144	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.98e-05	0.0014	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.95e-05	0.00138	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	1.94e-05	0.00137	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.94e-05	0.00137	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	1.93e-05	0.00137	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	1.87e-05	0.00132	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP2—focal segmental glomerulosclerosis	1.85e-05	0.00131	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.82e-05	0.00129	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.82e-05	0.00128	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—LIPC—focal segmental glomerulosclerosis	1.8e-05	0.00128	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.8e-05	0.00127	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.77e-05	0.00126	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	1.77e-05	0.00125	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.73e-05	0.00122	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.68e-05	0.00119	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	1.62e-05	0.00115	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.62e-05	0.00115	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.6e-05	0.00113	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CTGF—focal segmental glomerulosclerosis	1.59e-05	0.00112	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	1.56e-05	0.0011	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.55e-05	0.0011	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—LPL—focal segmental glomerulosclerosis	1.53e-05	0.00109	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.53e-05	0.00108	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.5e-05	0.00106	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.49e-05	0.00105	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—LPL—focal segmental glomerulosclerosis	1.49e-05	0.00105	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.48e-05	0.00105	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.47e-05	0.00104	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.46e-05	0.00103	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.39e-05	0.000986	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.39e-05	0.000986	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.36e-05	0.000965	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.33e-05	0.000944	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AGT—focal segmental glomerulosclerosis	1.31e-05	0.000929	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.31e-05	0.000929	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.3e-05	0.000922	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AGT—focal segmental glomerulosclerosis	1.27e-05	0.000901	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.26e-05	0.000893	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.26e-05	0.000889	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.25e-05	0.000888	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.15e-05	0.000813	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.15e-05	0.000812	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.14e-05	0.000804	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.12e-05	0.000793	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.11e-05	0.000787	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.11e-05	0.000786	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—LPL—focal segmental glomerulosclerosis	1.1e-05	0.000778	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.06e-05	0.000748	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.02e-05	0.000725	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ALB—focal segmental glomerulosclerosis	1.01e-05	0.000713	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	9.83e-06	0.000696	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ALB—focal segmental glomerulosclerosis	9.77e-06	0.000691	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	9.65e-06	0.000683	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ALB—focal segmental glomerulosclerosis	9.63e-06	0.000681	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	9.53e-06	0.000675	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.5e-06	0.000673	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—LPL—focal segmental glomerulosclerosis	9.45e-06	0.000669	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	9.41e-06	0.000666	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AGT—focal segmental glomerulosclerosis	9.41e-06	0.000666	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	9.3e-06	0.000658	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.09e-06	0.000644	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	8.29e-06	0.000587	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	8.11e-06	0.000574	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AGT—focal segmental glomerulosclerosis	8.08e-06	0.000572	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	8.03e-06	0.000568	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	7.95e-06	0.000563	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	7.78e-06	0.000551	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	7.7e-06	0.000545	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.64e-06	0.00054	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—focal segmental glomerulosclerosis	7.22e-06	0.000511	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	7.14e-06	0.000505	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	6.8e-06	0.000481	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	6.69e-06	0.000474	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	6.64e-06	0.00047	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	6.59e-06	0.000466	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.58e-06	0.000465	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—focal segmental glomerulosclerosis	6.2e-06	0.000439	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.97e-06	0.000423	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	5.89e-06	0.000417	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	5.84e-06	0.000414	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	5.74e-06	0.000407	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.43e-06	0.000384	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.38e-06	0.000381	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	5.22e-06	0.000369	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	5.07e-06	0.000359	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	5.06e-06	0.000358	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	4.95e-06	0.00035	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	4.91e-06	0.000348	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.38e-06	0.00031	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	4.23e-06	0.0003	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	4.09e-06	0.000289	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	4.05e-06	0.000287	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	3.85e-06	0.000273	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	3.77e-06	0.000267	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.55e-06	0.000251	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.49e-06	0.000247	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	3.46e-06	0.000245	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.68e-06	0.00019	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.67e-06	0.000189	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	2.66e-06	0.000188	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.28e-06	0.000162	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.75e-06	0.000124	CbGpPWpGaD
